Tenoten in the Therapy of Anxious Disturbances in Patients with Essential Hypertension and Coronary Heart Disease

被引：3
|
作者：
Vanchakova, N. P. [1 ]
Popov, A. P.
机构：
[1] IP Pavlov St Petersburg State Med Univ, Dept Psychiat & Narcol, St Petersburg, Russia
来源：
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2009年 / 148卷 / 02期
关键词：
tenoten; anxiolytic activity; autonomic hyperactivity; generalized anxiety disorders; anxiety level;
D O I：
10.1007/s10517-009-0682-0
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The study demonstrated high anxiolytic activity of tenoten, which was not inferior to the anxiolytic effect of grandaxin. The positive changes persisted after termination of treatment in the tenoten group (but not in grandaxin group). Tenoten can be recommended for the treatment of patients with cardiovascular diseases associated with neurotic disturbances.
引用
收藏
页码：343 / 345
页数：3
相关论文
共 50 条
  • [1] Tenoten in the Therapy of Anxious Disturbances in Patients with Essential Hypertension and Coronary Heart Disease
    N. P. Vanchakova
    A. P. Popov
    [J]. Bulletin of Experimental Biology and Medicine, 2009, 148 : 343 - 345
  • [2] Clinical Effects of Anxiolytic Preparation Tenoten in Complex Therapy of Essential Hypertension
    Nikol'skaya, I. N.
    Guseva, I. A.
    Bliznevskaya, E. V.
    Tret'yakova, T. V.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2009, 148 (02) : 346 - 348
  • [3] Serum uric acid and coronary heart disease in patients with essential hypertension
    Guo, Zhiping
    Lin, Jinxiu
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 137 : S7 - S8
  • [4] Betacap efficiency in elderly patients with coronary heart disease and essential hypertension
    Zaslavskaya, RM
    Goncharov, LF
    Zholdin, BK
    Bisengalieva, GK
    [J]. TERAPEVTICHESKII ARKHIV, 1998, 70 (01): : 24 - 26
  • [5] Clinical Effects of Anxiolytic Preparation Tenoten in Complex Therapy of Essential Hypertension
    I. N. Nikol’skaya
    I. A. Guseva
    E. V. Bliznevskaya
    T. V. Tret’yakova
    [J]. Bulletin of Experimental Biology and Medicine, 2009, 148 : 346 - 348
  • [6] ANALYSIS OF RISK FACTORS FOR PATIENTS WITH ESSENTIAL HYPERTENSION COMBINING CORONARY HEART DISEASE
    Kuang Zemin
    Jiang Wei-hong
    Tang Xiao-hong
    Yuan Hong
    [J]. HEART, 2013, 99 : E205 - E205
  • [7] Combined antihypertensive therapy in patients with arterial hypertension and coronary heart disease
    Ageenkova, O. A.
    Milyagin, V. A.
    Purygina, M. A.
    [J]. CARDIOVASCULAR THERAPY AND PREVENTION, 2011, 10 (03): : 28 - 34
  • [8] Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension
    Gazzaruso, C
    Buscaglia, P
    Garzaniti, A
    Falcone, C
    Mariotti, S
    Savino, S
    Bonetti, G
    Finardi, G
    Geroldi, D
    [J]. JOURNAL OF HYPERTENSION, 1997, 15 (03) : 227 - 235
  • [9] INFLUENCE OF ISOPTIN ON THE HEMODYNAMICS OF PATIENTS WITH ESSENTIAL-HYPERTENSION AND CORONARY HEART-DISEASE
    ZASLAVSKAYA, RM
    BUBENOVA, LA
    VILKOVYSKY, FA
    MALKIN, LM
    OLEVSKY, IK
    [J]. KLINICHESKAYA MEDITSINA, 1985, 63 (08): : 33 - 36
  • [10] CARDIL (DILTIAZEM) IN THE TREATMENT OF PATIENTS WITH CORONARY HEART-DISEASE AND ESSENTIAL-HYPERTENSION
    LEKHTONEN, L
    LEKHTONEN, A
    KUKES, VG
    OLBINSKAYA, LI
    MOISEEV, VS
    LYUSOV, VA
    LUMME, Y
    [J]. KARDIOLOGIYA, 1990, 30 (11) : 15 - 19
12345